B

Bioagilytix

Biotechnology Research · United States · 5,000 employees

54 Decision makers
+3 New (6 months)
5,000 Employees
$130M Revenue
2008 Founded

Organizational Chart of Bioagilytix

Roles identified within Bioagilytix's leadership team, from public professional data, updated 25 Oct 2026.

Department

Hiring This department is actively hiring right now.

Bioagilytix's Full Organizational Chart

Loading


Get their contacts on Zeliq →

Job title Department People Action

Decision makers at Bioagilytix by function

General management

Finance

See all Bioagilytix contacts on Zeliq

Decision makers at Bioagilytix

54 identified 5 C-Level 6 VP 43 Directors +3 new (6 months)
See them on Zeliq →

Departments actively hiring 3 departments

General management
Project management
Research

These departments at Bioagilytix are actively recruiting: a strong signal to time your outreach.

Funding and news at Bioagilytix

Funding

Last round Private equity
Total funding $30M (2 rounds)
Venture Round $30M Feb 2019
Private Equity Round N/A Nov 2021

Latest news at Bioagilytix

  1. Appointment

    New Associate Director appointed — General management

  2. Appointment

    New Associate Director appointed — General management

Get these new hires' email and phone →

Team Structure headcount by department

Hiring Research
206
Operations
104
Other
89
Finance
85
Hiring General Management
66
Hiring Project Management
63
Technical
38
Medical
21

How to prospect Bioagilytix's departments

Research

With 206 people, this is the organisation's biggest team, and it is hiring. Long cycles and rigorous methods: respect their pace and bring evidence, not hype.

Operations

The company's second-largest department (104 people). Pitch measurable time savings and error reduction: the metrics this function is judged on.

Other

This department counts 89 people. Mixed profiles gather here: a discovery-first approach works better than a packaged pitch.

Finance

85 people work in this department. Build your pitch around ROI, payback period and risk reduction: the language this department speaks.

General Management

A team of 66 people, currently hiring. Executive attention is scarce: one sharp sentence on business impact beats three paragraphs of features.

Project Management

This 63-person department is actively recruiting. Methodology debates are constant here: anchor your pitch in their existing framework rather than against it.

Try the Zeliq email finder demo →

FAQ Bioagilytix

Who runs Bioagilytix?

The highest-ranking leadership role identified at Bioagilytix is “CFO”, based on public data updated 25 Oct 2026.

How many decision makers does Bioagilytix have?

54 decision makers identified, including 5 at executive level.

How do I contact a decision maker at Bioagilytix?

Verified emails and phone numbers are available in Zeliq, with free credits at sign-up.

Which departments are hiring at Bioagilytix?

General management, Project management and Research, based on published job offers as of 25 Oct 2026.

Companies similar to Bioagilytix

More companies to explore

Biotechnology Research · United States

All Biotechnology Research companies in United States →

About Bioagilytix

Bioagilytix is a business specialised in Biotechnology Research, operating from United States. Founded in 2008, the company has a workforce of roughly 5,000 people. Bioagilytix belongs to the Professional Services sector, with a specific positioning on Biotechnology Research. Bioagilytix sells primarily to other businesses (B2B) rather than to end consumers. Bioagilytix has raised funding across 2 rounds totalling $30M. Its estimated yearly revenue stands at about $130M. Sales teams can rely on this profile to qualify Bioagilytix, spot business signals, and connect with verified decision makers.

Activity & Market

Bioagilytix operates in the Biotechnology Research segment, part of the broader Professional Services sector. As a B2B company, Bioagilytix primarily serves business clients and professional organisations. The company is categorised as “Privately held”.